BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
53.29
+0.34 (0.64%)
At close: Oct 17, 2025, 4:00 PM EDT
53.29
0.00 (0.00%)
After-hours: Oct 17, 2025, 4:20 PM EDT

BioMarin Pharmaceutical Stock Forecast

Stock Price Forecast

The 17 analysts that cover BioMarin Pharmaceutical stock have a consensus rating of "Buy" and an average price target of $93.71, which forecasts a 75.85% increase in the stock price over the next year. The lowest target is $60 and the highest is $126.

Price Target: $93.71 (+75.85%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$60$93.71$96$126
Change+12.59%+75.85%+80.15%+136.44%

Analyst Ratings

The average analyst rating for BioMarin Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingMay '25Jun '25Jul '25Aug '25Sep '25Oct '25
Strong Buy666764
Buy10101111117
Hold666677
Sell000000
Strong Sell000000
Total222223242418

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
JP Morgan
JP Morgan
Buy
Maintains
$116$119
BuyMaintains$116$119+123.31%Oct 9, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Initiates
$60
HoldInitiates$60+12.59%Sep 8, 2025
Guggenheim
Guggenheim
Strong Buy
Maintains
$101$106
Strong BuyMaintains$101$106+98.91%Aug 6, 2025
UBS
UBS
Strong Buy
Maintains
$113$114
Strong BuyMaintains$113$114+113.92%Aug 5, 2025
Morgan Stanley
Morgan Stanley
Buy
Maintains
$97$96
BuyMaintains$97$96+80.15%Jul 22, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
3.24B
from 2.85B
Increased by 13.35%
Revenue Next Year
3.53B
from 3.24B
Increased by 9.18%
EPS This Year
3.52
from 2.21
Increased by 59.65%
EPS Next Year
4.54
from 3.52
Increased by 28.81%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.86B1.85B2.10B2.42B2.85B3.24B3.53B
Revenue Growth
9.18%-0.76%13.53%15.42%17.97%13.35%9.18%
EPS
4.50-0.350.750.872.213.524.54
EPS Growth
---16.00%153.71%59.65%28.81%
Forward PE
-----15.1211.74
No. Analysts
-----3029
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High3.4B3.9B
Avg3.2B3.5B
Low3.0B3.1B

Revenue Growth

Revenue Growth20252026202720282029
High
18.3%
20.2%
Avg
13.4%
9.2%
Low
5.8%
-3.2%

EPS Forecast

EPS20252026202720282029
High4.386.21
Avg3.524.54
Low2.503.16

EPS Growth

EPS Growth20252026202720282029
High
98.4%
76.1%
Avg
59.6%
28.8%
Low
13.2%
-10.5%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.